Aptean Teaches Kids to Code During Computer Science Education Week
Dec 11, 2017 15:53 pm UTC| Business
ALPHARETTA, Ga., Dec. 11, 2017 -- Aptean, a leading global provider of mission-critical enterprise software solutions, joined companies across the country last week in hosting an Hour of Code event for local children at...
StayinFront to Roll Out Automated Testing Solution Globally for Consumer Goods Companies
Dec 11, 2017 15:49 pm UTC| Business
Fairfield, NJ, Dec. 11, 2017 -- StayinFront, a global leader in mobile, cloud-based field solutions for the consumer goods industry, announced today that it has signed global agreements with two Fortune 500 companies to...
Dec 11, 2017 15:45 pm UTC| Business
Encouraging initial anti-leukemic activity with durable responses and acceptable tolerability observed in dose expansion cohortData supports combination with MGA012 (anti-PD-1) to potentially enhance anti-leukemic effects ...
Christmas Cookie Party Perfection
Dec 11, 2017 15:42 pm UTC| Business
MISSION, Kan., Dec. 11, 2017 -- (Family Features) The next best thing to baking cookies for many home chefs is baking cookies with friends. Dust off your favorite recipes, create a festive playlist and fill your home...
U.S. commercial insurance prices stay nearly flat during the third quarter
Dec 11, 2017 15:39 pm UTC| Business
ARLINGTON, Va., Dec. 11, 2017 -- Commercial insurance prices in the U.S. were again nearly flat during the third quarter of 2017, according to leading global advisory, broking and solutions company Willis Towers...
5 Tips for Finding College Scholarships
Dec 11, 2017 15:37 pm UTC| Business
MISSION, Kan., Dec. 11, 2017 -- (Family Features) College is a significant investment and millions of families each year face the question of how to pay for it. One way students can position themselves for success is by...
Thetis Builds Scientific Advisory Board to Guide Development of Immuno-Resolving Therapies for IBD
Dec 11, 2017 15:35 pm UTC| Business
BRANFORD, Conn., Dec. 11, 2017 -- Thetis Pharmaceuticals LLC (“Thetis”), a biopharmaceutical company developing oral, “immuno-resolving” therapies to treat inflammatory bowel disease (IBD), announced that Stephen...
China's Economic Resurgence: Strong Growth Signals a Bright Future Ahead
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update